Partial
Mostly Misaligned
Patient Risk:
Medium
Summary
Partially aligns: the response reflects the label’s boxed warning concepts (GI bleeding/ulceration and CV thrombotic risk) and the warfarin/anticoagulant bleeding synergy with monitoring. However, many detailed interaction/precaution claims (beyond warfarin/analgesic-dose aspirin) and multiple specific bleeding-warning signs are not supported by the provided label text and appear to go beyond what is stated.
Category Scores
Accurate Statements
Combining ibuprofen with blood thinners should often be avoided because both can increase bleeding risk.
Supported by label: Ibuprofen and anticoagulants such as warfarin have a synergistic effect on bleeding with increased risk of serious bleeding (7 DRUG INTERACTIONS).
The interaction safety plan for ibuprofen can differ depending on the specific blood thinner and dose.
Supported in part: label advises monitoring patients with concomitant use and references increased risk; however, the label text provided does not explicitly state that the plan differs by specific anticoagulant. (Partial support—see unsupported/omitted.)
If a clinician says it is acceptable, the lowest effective dose for the shortest possible time should be used.
Supported by label dosing/administration and CV warning: use lowest effective dosage for shortest duration consistent with goals (2 DOSAGE AND ADMINISTRATION; 5.1).
Other bleeding-risk medicines (for example, additional NSAIDs, aspirin unless specifically directed, or other antiplatelets) should be avoided at the same time unless directed by a clinician.
Partially supported: label says concomitant use of CALDOLOR and analgesic doses of aspirin is not generally recommended due to increased bleeding risk (7 DRUG INTERACTIONS). Label text provided does not address additional NSAIDs or antiplatelets specifically in the provided excerpt.
The right precaution is to confirm whether ibuprofen is allowed for the specific blood thinner.
Supported in concept by label interaction guidance to monitor with concomitant use; however, the label does not contain this exact wording. Conceptually aligned with interaction monitoring/recommendations (7 DRUG INTERACTIONS).
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include black or tarry stools.
Label excerpt identifies GI bleeding but does not list specific warning-sign examples.
Unsupported Statements
Ibuprofen can worsen platelet function.
No support in the provided label sections.
Ibuprofen can irritate the stomach lining, which raises the chance of bleeding.
Label excerpt uses terms like inflammation/bleeding/ulceration/perforation, but the provided text does not support the specific phrasing about 'irritate the stomach lining' increasing bleeding risk.
The interaction risk is a concern for warfarin and many other anticoagulants.
Label text provided explicitly mentions 'anticoagulants such as warfarin' but does not enumerate 'many other anticoagulants.'
The interaction risk is a concern for many anticoagulants and antiplatelet drugs.
Label excerpt provided only explicitly mentions warfarin (anticoagulant) and analgesic-dose aspirin; it does not support a generalized statement including 'antiplatelet drugs' or 'many' anticoagulants.
Precautions should include confirming which specific blood thinner medication the person takes (e.g., warfarin, apixaban, rivaroxaban, dabigatran, edoxaban, clopidogrel, aspirin).
The provided label text does not list or discuss these specific drugs; it only explicitly provides warfarin as an example and addresses aspirin (analgesic doses).
Key precautions include asking whether the person should avoid ibuprofen completely or use an alternative pain or fever medicine.
The label excerpt provided includes guidance to use lowest effective dose/shortest duration and monitoring, but does not support the specific alternative-medicine instruction.
Other bleeding-risk medicines (for example, additional NSAIDs, aspirin unless specifically directed, or other antiplatelets) should be avoided at the same time unless directed by a clinician.
Only aspirin (analgesic doses) is addressed in the provided interaction excerpt; additional NSAIDs and antiplatelets are not supported.
Alcohol and other supplements or medicines that can affect bleeding risk can increase bleeding risk and should be reviewed with a pharmacist.
No support in the provided label excerpt.
Many clinicians prefer acetaminophen (paracetamol) instead of NSAIDs for pain or fever in people on blood thinners.
No support in the provided label excerpt.
Acetaminophen does not work the same way on platelets and does not cause the same stomach irritation as NSAIDs.
No support in the provided label excerpt (and 'does not work... on platelets' is not addressed).
Clinician guidance on acetaminophen should be based on the person's health history, especially liver disease.
No support in the provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include blood in stool.
The label excerpt mentions GI bleeding but does not list specific sign items like 'blood in stool.'
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include vomiting blood.
No specific warning-sign listing in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include coffee-ground material.
No support for this specific warning sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include unusual or heavy bruising.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include prolonged bleeding from cuts.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include frequent nosebleeds.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include bleeding gums.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include blood in urine.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include severe or worsening headache.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include dizziness.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include weakness.
No support for this specific sign in provided label excerpt.
If ibuprofen is combined with a blood thinner, warning signs of abnormal bleeding include new neurologic symptoms, which can indicate internal bleeding.
Label excerpt discusses CV thrombotic events and serious GI events, but does not support this specific warning-sign interpretation.
If any bleeding warning signs occur after combining ibuprofen with a blood thinner, urgent medical help should be sought.
The provided label excerpts include 'monitor' for signs of bleeding, but do not provide this specific urgency instruction.
Even one dose of ibuprofen can raise bleeding risk when combined with a blood thinner.
Label excerpt does not quantify timing such as 'even one dose.'
Timing ibuprofen farther apart is not a reliable safety strategy when combined with a blood thinner.
Label excerpt does not address timing strategies or reliability.
If a person already took ibuprofen, they should not take extra doses to catch up.
No support in provided label excerpt.
If a person already took ibuprofen while on a blood thinner, they should contact a pharmacist or prescriber for individualized advice based on the blood thinner, dose, and timing.
Label excerpt provides interaction monitoring, but does not support this specific advice pathway/phrasing.
If a person develops any bleeding warning signs after taking ibuprofen with a blood thinner, they should get urgent care.
The provided label excerpt does not specify 'urgent care' or tie it to 'any bleeding warning signs' wording.
Acetaminophen/paracetamol is expected to be safer than NSAIDs for pain or fever in people on blood thinners.
No support in the provided label excerpt.
Contradictions
Important Omissions
Boxed-warning-specific CV thrombotic risk consequences (e.g., MI/stroke) and that risk may occur early and may increase with duration, as part of the broader warning context for NSAIDs.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Several claims go beyond the provided label text by listing many specific bleeding signs, making generalized statements about 'many' anticoagulants and antiplatelet drugs, and asserting comparative safety of acetaminophen in blood-thinner users. While the response captures the label’s general bleeding interaction concept (warfarin and anticoagulants; aspirin analgesic doses) and dose/duration minimization, unsupported specificity increases hallucination risk.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Misaligned
Primary Issue
Overextended and unsupported claims (specific drugs, antiplatelet/general anticoagulant scope, detailed warning-sign list, acetaminophen comparative safety and mechanism) not present in the provided CALDOLOR label excerpts.
Suggested Improvement
Restrict claims to what the label excerpt supports: (1) boxed warning of serious CV thrombotic events and serious GI bleeding/ulceration/perforation; (2) dose/duration minimization; (3) interaction statement about anticoagulants such as warfarin synergistically increasing bleeding and monitoring for signs of bleeding; (4) aspirin (analgesic doses) not generally recommended due to increased bleeding risk. Avoid enumerating specific bleeding-sign examples, specific DOAC/antiplatelet drug lists, and comparative acetaminophen safety/platelet statements unless directly supported by the label text provided.